跳至主要内容
临床试验/NCT04194398
NCT04194398已完成不适用

OCS Lung Expand Post-Approval Study - Expand Follow-Up Data Collection

TransMedics8 个研究点 分布在 3 个国家目标入组 79 人开始时间: 2018年12月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
TransMedics
入组人数
79
试验地点
8
主要终点
Patient and graft survival

研究概览

简要总结

Collection of five year follow-up data on patients who have already participated in the EXPAND Lung trial and have had transplants with donor lungs preserved on the OCS Lung System.

详细描述

The purpose of this continuation study is to collect five year follow-up data on patients who have already participated in the EXPAND Lung trial and have had transplants with donor lungs preserved on the OCS Lung System. The EXPAND Lung trial results have been presented and have shown positive results in the use of expanded criteria donor lungs and patient follow-up, post-transplant. The current study is being conducted to continue to collect follow-up on participants in the EXPAND study, in order to evaluate long-term patient survival status and BOS diagnosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Registered male or female primary double lung transplant candidate
  • Age ≥18 years old
  • Signed: 1) written informed consent document and 2) authorization to use and disclose protected health information

排除标准

  • Prior solid organ or bone marrow transplant
  • Single lung recipient
  • Chronic use of hemodialysis or diagnosis of chronic renal insufficiency

结局指标

主要结局

Patient and graft survival

时间窗: 5 years

Survival of graft and survival as evaluated at follow-up visit/call with patient or health care provider.

Presence or absence of bronchiolitis obliterans sydrome (BOS)

时间窗: 5 years

Evaluation of BOS as determined by follow-up evaluation visit/call with patient or health care provider.

次要结局

未报告次要终点

研究者

发起方
TransMedics
申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验

OCS Lung Expand Post-Approval Study - Expand... | 临床试验